Literature DB >> 34907717

Antepartum and postpartum changes in adipokines, endothelial dysfunction, inflammatory markers and other biochemical parameters in preeclamptic women: A prospective observational cohort study.

Amany Yasseen Talab1, Haitham Aboali Hamza2, Tarek Mohamed Mostafa1.   

Abstract

This study aimed at evaluating the role played by insulin resistance, lipid metabolism disorder, oxidative stress, resistin, vaspin, Interleukin-18 and asymmetric dimethyl arginine as a marker for endothelial dysfunction in the pathogenesis of preeclampsia. This prospective observational cohort study involved 60 women who were classified into: 20 non-pregnant women (group 1 or control group), 20 normally pregnant women (group 2) and 20 preeclamptic women (group 3) at their third trimester. The pregnant women were assessed at their third trimester and further re-evaluated four weeks after delivery. The assessment included demography, assessment of proteinuria and urinary protein to creatinine ratio, blood pressure measurement and assessment of fasting blood glucose, fasting insulin level, lipid panel and the circulating levels of malondialdehyde, resistin, vaspin, interleukin-18 and asymmetric dimethyl arginine. Preeclamptic women showed more atherogenic lipid profile, significantly higher Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) and significantly elevated levels of malondialdehyde, resistin, vaspin and interleukin-18 than the other study groups. Serum asymmetric dimethyl arginine concentration showed non-significant difference among the three study groups. The levels of resistin and vaspin showed significant decrease four weeks postpartum in preeclamptic group. We concluded that, preeclampsia was associated with insulin resistance, dyslipidemia, oxidative stress, inflammation and significant changes in adipokines; resistin and vaspin. Furthermore, the significant increase in the serum levels of resistin and vaspin at the third trimester and their significant decline four weeks postpartum in preeclamptic group focus the attention on the role played by these adipokines in the pathogenesis of preeclampsia.

Entities:  

Keywords:  Asymmetric dimethyl arginine; Interleukin-18; Malondialdehyde; Preeclampsia; Resistin; Vaspin

Mesh:

Substances:

Year:  2021        PMID: 34907717     DOI: 10.32725/jab.2021.004

Source DB:  PubMed          Journal:  J Appl Biomed        ISSN: 1214-021X            Impact factor:   1.797


  45 in total

1.  Central nervous system and limb anomalies in case reports of first-trimester statin exposure.

Authors:  Robin J Edison; Maximilian Muenke
Journal:  N Engl J Med       Date:  2004-04-08       Impact factor: 91.245

2.  Malondialdehyde determination as index of lipid peroxidation.

Authors:  H H Draper; M Hadley
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  Urinary levels of nitric oxide metabolites in normal pregnancy and preeclampsia.

Authors:  S Begum; M Yamasaki; M Mochizuki
Journal:  J Obstet Gynaecol Res       Date:  1996-12       Impact factor: 1.730

4.  Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells.

Authors:  Changyi Chen; Jun Jiang; Jian-Ming Lü; Hong Chai; Xinwen Wang; Peter H Lin; Qizhi Yao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-30       Impact factor: 4.733

5.  Spot protein/creatinine ratio in preeclampsia as an alternative for 24-hour urine protein.

Authors:  Oya Demirci; Pınar Kumru; Arzu Arınkan; Cem Ardıç; Resul Arısoy; Elif Tozkır; Bülent Tandoğan; Habibe Ayvacı; Ahmet S Tuğrul
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

Review 6.  The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP).

Authors:  M A Brown; M D Lindheimer; M de Swiet; A Van Assche; J M Moutquin
Journal:  Hypertens Pregnancy       Date:  2001       Impact factor: 2.108

7.  Delta-aminolevulinate dehydratase activity and oxidative stress markers in preeclampsia.

Authors:  Leidiane de Lucca; Fabiane Rodrigues; Letícia B Jantsch; Helena Kober; Walter S Neme; Francisco M P Gallarreta; Thissiane L Gonçalves
Journal:  Biomed Pharmacother       Date:  2016-09-19       Impact factor: 6.529

8.  Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.

Authors:  Fiona C Brownfoot; Stephen Tong; Natalie J Hannan; Natalie K Binder; Susan P Walker; Ping Cannon; Roxanne Hastie; Kenji Onda; Tu'uhevaha J Kaitu'u-Lino
Journal:  Hypertension       Date:  2015-07-27       Impact factor: 10.190

9.  Estimating rate of insulin resistance in patients with preeclampsia using HOMA-IR index and comparison with nonpreeclampsia pregnant women.

Authors:  Farideh Rezaei Abhari; Maryam Ghanbari Andarieh; Asadollah Farokhfar; Soleiman Ahmady
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

10.  Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial.

Authors:  A Ahmed; D J Williams; V Cheed; L J Middleton; S Ahmad; K Wang; A T Vince; P Hewett; K Spencer; K S Khan; J P Daniels
Journal:  BJOG       Date:  2019-12-14       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.